FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#14 | |||
|
||||
Magnate
|
Today: http://www.docguide.com/news/content...2574CF004C9F51
(keep in mind the last line of the article: The current study received funding for data analysis from TEVA, the manufacturer of glatiramer acetate. ) Still.. as I see it, more positive news on the C front. ![]()
__________________
2004 to present - Trigeminal Neuralgia 2007 to present - Burning Mouth Syndrome March 2008 - Multiple Sclerosis DX 05/2008 - Relapse 05/2008 to 02/2009 - Copaxone 10/2011 - Relapse - Optic Neuritis developed 9/2012 - Relapse - Balance issues 1 sided 8/2012 - Erythema Nodosum - diagnosed 10/2012, reaction to Topiramate (Topamax) April 7/14 - Raynaud's Syndrome DX |
|||
![]() |
![]() |
"Thanks for this!" says: | GladysD (10-06-2008) |
|
|
![]() |
||||
Thread | Forum | |||
High-dosage Copaxone trial results are bad news for Teva | ALS News & Research | |||
Ceregene announces positive phase 1 results ... | Parkinson's Disease | |||
Positive Results of Phase 3 Study of Fampridine-SR on walking | Multiple Sclerosis |